Susan Adelegan

Beringea is an active manager which invests in dynamic businesses led by exceptional management in the healthcare, media, brands and intellectual property sectors, partnering with investee businesses to provide resources to develop strategy, evaluate growth opportunities, solve problems and build value. Their ProVen VCT invests in a diversified portfolio of unquoted and AIM-listed companies with the potential for significant value increases. After investing, the firm remains closely involved in the investee businesses, aiming to add value wherever possible and seeking to identify opportunities for profitable exits as the company's value increases. The firm's PGI VCT specializes in early-stage and growth company investments across a range of sectors. Beringea's InvestCare Partners, LP provides equity to medium-sized, privately owned mid- to late-stage US healthcare businesses, typically investing between $2 and $5 million. Their Global Rights Fund II invests in all growth stages of US and UK media, content, brands, enabling technology and intellectual property rights companies, seeking to exploit intellectual property rights across media platforms. Beringea typically invests $1-$5 million in Global Rights Fund II companies.

Functions as a College/University

H2O AM uses a top-down approach to find a balance between enhancing value and mitigating risk through statistical and objective diversification. Their investment process is based on their beliefs that value investment offers a strong and stable success ratio over the long run; that diversification creates value and is the best way to absorb short- and medium-term volatility; and that risk is always an input to generate structural risk-adjusted alpha. They examine the relative value of different sectors, segments and countries to make their final selection.